Breast Cancer Oncological Outcomes at an Italian Center Following Nipple-Sparing and Skin-Sparing Mastectomy Techniques

被引:1
|
作者
Bertozzi, Serena [1 ,2 ]
Londero, Ambrogio Pietro [3 ,4 ]
Seriau, Luca [1 ]
Passafiume, Federica [1 ]
Moschella, Sara [1 ]
Morinelli, Vittoria [1 ]
Andretta, Michela [1 ]
Orsaria, Maria [5 ]
Mariuzzi, Laura [5 ]
Parodi, Pier Camillo [6 ]
Risaliti, Andrea [7 ]
Cedolini, Carla [1 ,2 ]
机构
[1] Acad Hosp Udine, Breast Unit, I-33100 Udine, Italy
[2] Ennergi Res, I-33050 Lestizza, Italy
[3] Univ Genoa, Dept Neurosci Rehabil Ophthalmol Genet Maternal &, I-16132 Genoa, Italy
[4] IRCCS Ist Giannina Gaslini, Obstet & Gynecol Unit, I-16147 Genoa, Italy
[5] Acad Hosp Udine, Inst Pathol Anat, DAME, I-33100 Udine, Italy
[6] Acad Hosp Udine, Clin Plast Surg, DAME, I-33100 Udine, Italy
[7] Univ Udine, Clin Surg, DAME, I-33100 Udine, Italy
来源
关键词
breast cancer; nipple-sparing mastectomy; skin-sparing mastectomy; disease-free survival; breast-conserving surgery; mod-ified total mastectomy; overall survival; local recurrence; IMMEDIATE RECONSTRUCTION; AUTOLOGOUS RECONSTRUCTION; LOCAL RECURRENCE; AREOLA COMPLEX; SAFETY; RISK; CONSERVATION; PATIENT; IMPACT;
D O I
10.31083/j.ceog5005094
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Background: The introduction of skin-sparing mastectomy (SSM) and nipple-sparing mastectomy (NSM) with immediate reconstruction allowed a noticeable improvement in reconstructive surgery aesthetic results and patients' psychophysical well-being. In any case, there are still concerns about the long-term oncological safety of these two procedures. This study aims to assess the oncological outcomes of women who underwent SSM and NSM and to compare them with traditional modified total mastectomy (MTM). The secondary outcome was to compare mastectomy with breast-conserving surgery (BCS) outcome. Methods: We performed a retrospective chart review study concerning all patients who had experienced SSM and NSM in our Clinic between January 2004 and July 2013. The main outcomes were overall survival (OS), disease-free survival (DFS), and recurrences cumulative rate. Results: Among this study's 1836 invasive breast carcinomas, we found NSM (86.7, 95% confidence interval (CI), 76.7-98.0%) to have a significantly shorter 5-year DFS than MTM (90.4%, 95% CI, 87.9-93.0%). Furthermore, low body mass index (odds ratio (OR) 0.733, p = 0.056), basal-like molecular subtype (OR 28.932, p < 0.05), extended intraductal component (OR 11.160, p = 0.107), and lymph node metastasis extracapsular invasion (OR 8.727, p = 0.077) were the most significant predictors of recurrence in women treated with NSM. Furthermore, patients with BCS had significantly longer OS and DFS than those who underwent MTM. Conclusions: Occult nipple neoplastic involvement following negative intraoperative histological examination of subareolar tissue may explain the higher recurrence rate among women undergoing NSM. Patients with one or more risk factors for recurrence after NSM, such as basal-like molecular subtype, extended intraductal component, and extracapsular invasion of lymph node metastasis, should be given special attention.
引用
收藏
页数:11
相关论文
共 50 条
  • [31] Skin Reduction Nipple-Sparing Mastectomy
    Jill Dietz
    Greg Fedele
    Annals of Surgical Oncology, 2015, 22 : 3404 - 3404
  • [32] Nipple Loss following Nipple-Sparing Mastectomy
    Mastroianni, Melissa
    Lin, Alex M.
    Smith, Barbara L.
    Austen, William G., Jr.
    Colwell, Amy S.
    PLASTIC AND RECONSTRUCTIVE SURGERY, 2016, 138 (01) : 24E - 30E
  • [33] Oncological Outcomes of Nipple-Sparing Mastectomy: A Single-Center Experience of 1989 Patients
    Galimberti, Viviana
    Morigi, Consuelo
    Bagnardi, Vincenzo
    Corso, Giovanni
    Vicini, Elisa
    Ribeiro Fontana, Sabrina Kahler
    Naninato, Paola
    Ratini, Silvia
    Magnoni, Francesca
    Toesca, Antonio
    Kouloura, Andriana
    Rietjens, Mario
    De Lorenzi, Francesca
    Vingiani, Andrea
    Veronesi, Paolo
    ANNALS OF SURGICAL ONCOLOGY, 2018, 25 (13) : 3849 - 3857
  • [34] Nipple-sparing mastectomy: considerations and techniques
    Bury, Sean
    Crosby, Melissa
    Babiera, Gildy V.
    BREAST CANCER MANAGEMENT, 2013, 2 (01) : 57 - 69
  • [35] Oncological Outcomes of Nipple-Sparing Mastectomy: A Single-Center Experience of 1989 Patients
    Viviana Galimberti
    Consuelo Morigi
    Vincenzo Bagnardi
    Giovanni Corso
    Elisa Vicini
    Sabrina Kahler Ribeiro Fontana
    Paola Naninato
    Silvia Ratini
    Francesca Magnoni
    Antonio Toesca
    Andriana Kouloura
    Mario Rietjens
    Francesca De Lorenzi
    Andrea Vingiani
    Paolo Veronesi
    Annals of Surgical Oncology, 2018, 25 : 3849 - 3857
  • [36] Nipple Loss following Nipple-Sparing Mastectomy
    Jabir, Shehab
    PLASTIC AND RECONSTRUCTIVE SURGERY, 2017, 139 (03) : 794E - 794E
  • [37] Extended Indications for Nipple-Sparing Mastectomy: Comparative Oncological Outcomes of Nipple Preservation in All Stages Breast Cancer at a Single Academic Center
    Martel, K.
    Morency, D.
    Wong, S. M.
    Parvez, E.
    Dumitra, S.
    Meterissian, S.
    Hijal, T.
    Basik, M.
    Boileau, J.
    ANNALS OF SURGICAL ONCOLOGY, 2019, 26 : S102 - S103
  • [38] Oncological safety of nipple-sparing mastectomy in young patients with breast cancer compared with conventional mastectomy
    Huang, Jiapeng
    Mo, Qinguo
    Zhuang, Yaqiang
    Qin, Qinghong
    Huang, Zhen
    Mo, Junyang
    Tan, Qixing
    Lian, Bin
    Cao, Yiming
    Qin, Shuting
    Wei, Changyuan
    ONCOLOGY LETTERS, 2018, 15 (04) : 4813 - 4820
  • [39] Nipple-Sparing Mastectomy: Outcomes Discussion
    Cavalcante, Francisco Pimentel
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2020, 231 (05) : 605 - 605
  • [40] Factors Predicting Locoregional Recurrence After Neoadjuvant Chemotherapy and Nipple-Sparing/Skin-Sparing Mastectomy With Immediate Breast Reconstruction
    Wu, Zhen-Yu
    Kim, Hee Jeong
    Lee, Jong Won
    Chung, Il Yong
    Kim, Jisun
    Lee, Sae Byul
    Son, Byung-Ho
    Eom, Jin Sup
    Jeong, Jae Ho
    Gong, Gyungyub
    Kim, Hak Hee
    Ahn, Sei-Hyun
    Ko, BeomSeok
    FRONTIERS IN ONCOLOGY, 2021, 11